VEEV Stock Recent News
VEEV LATEST HEADLINES
Evaluate the expected performance of Veeva (VEEV) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to showcase innovations, including deep industry-specific Veeva AI in Vault Platform and Veeva applications PLEASANTON, Calif. , Aug. 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced highlights of its upcoming Veeva R&D and Quality Summit, where leaders across life sciences and Veeva exchange impactful ideas and innovations.
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
RESEARCH TRIANGLE PARK, N.C. & PLEASANTON, Calif.--(BUSINESS WIRE)--IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the long-term agreement, customers can use software, data, technology, and service offerings from Veeva and IQVIA together in a simple and efficient way. The global partnerships make it easy for customers to work with IQVIA and Veeva in key are.
Global partnerships to help customers improve clinical and commercial efficiency and effectiveness RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif.
Software companies are facing a reckoning as AI lowers barriers to entry. Experts share how to find winners in an evolving competitive landscape.
Veeva Systems (VEEV) concluded the recent trading session at $279.18, signifying a +1.36% move from its prior day's close.
The rapidly rising demand for cloud computing services is providing a tailwind to leaders in the field. If they play their cards right, some of those top players in the industry could deliver excellent returns for many years to come.
VEEV's strong first quarter, product innovations and strategic deals drive growth prospects despite rising costs.